4/A//SEC Filing
Ocain Tim 4/A
Accession 0001177648-18-000037
CIK 0001177648other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:21 PM ET
Size
5.8 KB
Accession
0001177648-18-000037
Insider Transaction Report
Form 4/AAmended
Ocain Tim
Senior Vice President
Transactions
- Award
Stock Option (right to buy)
2014-01-30+70,000→ 70,000 totalExercise: $32.27Exp: 2024-01-30→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]This amendment is being filed to correct the original Form 4 filing by amending the conversion or exercise price of the derivative security reported in column 2 from "$32.43" to "$32.27". This amendment corrects an administrative error.
- [F2]25% of the shares subject to the option will vest on the first anniversary of January 30, 2014 (the "Commencement Date"), and the remaining shares will vest in twelve (12) successive and equal quarterly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Commencement Date.
Documents
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001599020
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:21 PM ET
- Size
- 5.8 KB